6598 — Applied BioCode Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Applied BioCode, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	646	831	605	857	570
Net Total Accounts Receivable
Net Total Receivables	67.8	70.8	51	45	122
Total Inventory
Total Other Current Assets
Total Current Assets	826	1,014	837	1,104	858
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	163	170	131	98.8	145
Net Intangible Assets
Other Long Term Assets
Total Assets	1,019	1,212	993	1,215	1,013
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	59.9	87.6	102	130	127
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	116	396	332	336	369
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	903	816	661	879	643
Total Liabilities & Shareholders' Equity	1,019	1,212	993	1,215	1,013
Total Common Shares Outstanding